血管ステントの世界市場レポート 2025年

血管ステント市場規模は、今後数年で急成長が見込まれます。2029年にはCAGR10.4％で257億6,000万米ドルに成長します。予測期間における成長の背景には、予防的な心血管治療への注力、外来手術へのシフト、費用対効果と価値に基づくヘルスケア、生体吸収性ステントと次世代材料、血管内インターベンションの拡大などがあります。予測期間における主な動向には、ステントコーティングと材料の進歩、患者教育と意識向上、外来患者設定へのシフト、費用対効果の重視などがあります。

血管疾患の罹患率の増加が今後の血管ステント市場の成長を牽引すると予想されます。血管（動脈と静脈の両方）に影響を及ぼす血管疾患は、心血管疾患（CVD）に分類されます。血管ステントは、酸素を豊富に含む血液が心臓に流れやすくすることで、さまざまな血管疾患を治療するために使用されます。例えば、2023年5月、米国の公衆衛生に重点を置く連邦機関である疾病対策予防センター（CDC）は、2022年には約702,880人が心臓病で死亡すると報告しており、これは5人に1人が死亡する計算になります。その結果、心血管疾患（CVDs）の有病率が上昇し、血管ステント市場の成長に寄与することになります。

ヘルスケア支出の増加が血管ステント市場の成長を後押しすると予測されます。ヘルスケア支出とは、国や組織、個人が特定期間にヘルスケア関連の商品やサービスに割り当てる総資源を意味し、一般的には金額で測定されます。ヘルスケア支出の増加は、インフラの改善、医療施設の充実、意識の向上につながり、これらはすべて血管疾患の診断と治療にプラスの影響を与えます。例えば、2023年6月、米国を拠点に主要な医療プログラムを管理する組織であるメディケア＆メディケイドサービスセンター（CMS）は、「国民医療費予測2023-2024」の中で、米国の医療費成長率は今年5％、翌年5.1％になると予測していると報告しました。その結果、ヘルスケア支出の増加が血管ステント市場を前進させています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界の血管ステント PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の血管ステント市場：成長率分析
• 世界の血管ステント市場の実績：規模と成長, 2019-2024
• 世界の血管ステント市場の予測：規模と成長, 2024-2029, 2034F
• 世界の血管ステント総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の血管ステント市場：製品別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 冠動脈ステント
• 末梢血管ステント
• エバーステントグラフト
• 世界の血管ステント市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ベアメタルステント
• バイオエンジニアリングステント
• 生体吸収性血管スキャフォールド
• 薬剤溶出ステント
• デュアルセラピーステント
• 世界の血管ステント市場：材料別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 金属ステント
• コバルトクロム
• プラチナクロム
• ニッケルチタン
• ステンレス鋼
• ポリマーステント
• 世界の血管ステント市場：配送方法別、実績と予測, 2019-2024, 2024-2029F, 2034F
• バルーン拡張型ステント
• 自己拡張型ステント
• 世界の血管ステント市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 外来手術センター
• 心臓センター
• 病院
• 世界の血管ステント市場：冠動脈ステントのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 薬剤溶出性冠動脈ステント
• ベアメタル冠動脈ステント
• 世界の血管ステント市場：末梢血管ステントのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 薬剤溶出性末梢血管用ステント
• ベアメタル末梢ステント
• 世界の血管ステント市場：EVARステントグラフト（血管内動脈瘤修復）のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 大動脈腸骨ステントグラフト
• 窓付きステントグラフト
• 分岐ステントグラフト

第7章 地域別・国別分析

• 世界の血管ステント市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の血管ステント市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 血管ステント市場：競合情勢
• 血管ステント市場：企業プロファイル
  • Medtronic PLC Overview, Products and Services, Strategy and Financial Analysis
  • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
  • Biotronik SE & Co. KG Overview, Products and Services, Strategy and Financial Analysis
  • B. Braun Melsungen AG Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Terumo Corporation
• Meril Life Sciences Pvt. Ltd.
• JOTEC GmbH
• W. L. Gore & Associates Inc.
• MicroPort Scientific Corporation
• Translumina GmbH
• Lepu Medical Technology Co. Ltd.
• Purple Medical Solution Pvt. Ltd.
• Sahajanand Medical Technologies Pvt. Ltd.
• Stentys SA
• Osypka AG
• Cook Medical Inc.
• Cordis Corporation
• Endologix Inc.
• Johnson & Johnson Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 血管ステント市場2029：新たな機会を提供する国
• 血管ステント市場2029：新たな機会を提供するセグメント
• 血管ステント市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Vascular stents are intricately designed metal mesh tubes utilized in medical procedures to prevent vessel closure and enhance blood flow in narrowed or blocked veins and arteries. This intervention, commonly referred to as 'vascular stenting,' aims to minimize the risk of late restenosis while supporting swift recovery by widening obstructed arteries, thus reducing the likelihood of infections and physical complications.

The primary categories of vascular stent products include coronary stents, peripheral vascular stents, and EVAR stent grafts. Coronary stents specifically target constricted arteries supplying oxygenated blood to the heart, playing a crucial role in maintaining arterial patency post-angioplasty. Within the vascular stent market, these stents encompass various types such as bare metal stents, bio-engineered and bioresorbable vascular scaffolds, drug-eluting stents, and dual therapy stents. These stents are crafted from materials like cobalt-chromium, platinum-chromium, nickel titanium, stainless steel, and polymers. Their deployment methods involve balloon-expandable and self-expanding stents, utilized across ambulatory surgical centers, cardiac facilities, and hospitals.

The vascular stent market research report is one of a series of new reports from The Business Research Company that provides vascular stent market statistics, including vascular stent industry global market size, regional shares, competitors with a vascular stent market share, detailed vascular stent market segments, market trends and opportunities, and any further data you may need to thrive in the vascular stent industry. This vascular stent market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The vascular stent market size has grown strongly in recent years. It will grow from $15.85 billion in 2024 to $17.36 billion in 2025 at a compound annual growth rate (CAGR) of 9.5%. The growth in the historic period can be attributed to clinical research and development, drug-eluting stents (des), introduction of balloon angioplasty, early stent innovations, physician training and skill development.

The vascular stent market size is expected to see rapid growth in the next few years. It will grow to $25.76 billion in 2029 at a compound annual growth rate (CAGR) of 10.4%. The growth in the forecast period can be attributed to focus on preventive cardiovascular care, shift towards outpatient procedures, cost-effectiveness and value-based healthcare, bioabsorbable stents and next-generation materials, expansion of endovascular interventions. Major trends in the forecast period include advancements in stent coatings and materials, patient education and awareness, shift towards outpatient settings, focus on cost-effectiveness.

The growing incidence of vascular diseases is expected to drive the vascular stent market's growth in the future. Vascular disease, which affects the blood vessels (both arteries and veins), falls under the category of cardiovascular diseases (CVD). Vascular stents are used to treat various vascular diseases by facilitating the flow of oxygen-rich blood to the heart. For example, in May 2023, the Centers for Disease Control and Prevention (CDC), a federal agency in the United States focused on public health, reported that approximately 702,880 individuals died from heart disease in 2022, which translates to 1 in every 5 deaths. As a result, the rising prevalence of cardiovascular diseases (CVDs) will contribute to the growth of the vascular stent market.

The rise in healthcare expenditure is anticipated to boost the growth of the vascular stent market. Healthcare expenditure refers to the total resources allocated, typically measured in monetary terms, by a country, organization, or individual for healthcare-related goods and services over a specific period. Higher healthcare spending leads to better infrastructure, enhanced healthcare facilities, and increased awareness, all of which positively influence the diagnosis and treatment of vascular diseases. For example, in June 2023, the Centers for Medicare & Medicaid Services (CMS), a U.S.-based organization that administers major healthcare programs, reported in the National Health Expenditure Projections 2023-2024 that health expenditure growth rates in the United States are expected to be 5% this year and 5.1% the following year. Consequently, rising healthcare expenditure is propelling the vascular stent market forward.

Technological advancement is a significant trend gaining traction in the vascular stent market. Numerous companies are investing in bio-sensing devices, state-of-the-art integrated stents, and drug-eluting coronary stent systems to secure a competitive advantage. For example, in 2022, Translumina, a medical equipment manufacturer based in India, introduced the VIVO ISAR, a next-generation dual drug polymer-free coated stent (DDCS) that combines a stent with an enhanced safety profile without sacrificing drug release kinetics. It utilizes Probucol, an antioxidant and lipid-lowering agent, as a carrier to release Sirolimus (an anti-restenosis medication), thus creating a polymer-free drug-eluting stent platform with uncompromised safety and effectiveness.

Major companies are strategically partnering with start-ups and mid-sized firms in the vascular stent market to expand their product and service offerings. Such collaborations and partnership agreements enable companies to enhance their existing product portfolios and extend their geographical reach. For instance, in September 2023, The Electrospinning Company, a UK-based manufacturer of advanced biomaterials for implantable tissue-regenerative devices, collaborated with Relisys Medical Devices, an India-based producer of highly innovative cardiovascular medical devices, to develop groundbreaking products that could enhance cardiovascular care and transform patient outcomes. Through this partnership, the Electrospinning Company's Caladrix technology allows for the deposition of a thin, functional polymer coating without the need for sutures, enabling the manufacturing of vascular stents with improved production rates and yields while maintaining efficacy.

In January 2024, Olympus Corporation, a Japan-based company specializing in the development, manufacture, and sale of medical technology and precision instruments, acquired Taewoong Medical Co., Ltd. for $0.370 billion. This acquisition is intended to strengthen Olympus Corporation's gastrointestinal product portfolio, enhance patient outcomes, and broaden its global market presence in the GI medical device sector. Taewoong Medical Co., Ltd., a manufacturing company based in South Korea, produces vascular stents designed to treat narrowed blood vessels and improve circulation.

Major companies operating in the vascular stent market are Medtronic PLC, Abbott Laboratories, Boston Scientific Corporation, Biotronik SE & Co. KG, B. Braun Melsungen AG, Terumo Corporation, Meril Life Sciences Pvt. Ltd., JOTEC GmbH, W. L. Gore & Associates Inc., MicroPort Scientific Corporation, Translumina GmbH, Lepu Medical Technology Co. Ltd., Purple Medical Solution Pvt. Ltd., Sahajanand Medical Technologies Pvt. Ltd., Stentys SA, Osypka AG, Cook Medical Inc., Cordis Corporation, Endologix Inc., Johnson & Johnson Inc., EP Medsystems Inc.

North America was the largest region in the vascular stent market share in 2024. The regions covered in the vascular stent market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the vascular stent market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The vascular stent market consists of sales of bare metal stents, bioresorbable scaffold systems, and drug-eluting balloons. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Vascular Stent Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on vascular stent market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for vascular stent ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The vascular stent market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Coronary Stents; Peripheral Vascular Stents; Ever Stent Grafts
• 2) By Type: Bare Metal Stent; Bio-Engineered Stent; Bioresorbable Vascular Scaffold; Drug Eluting Stent; Dual Therapy Stent
• 3) By Material: Metallic Stents; Cobalt-Chromium; Platinum Chromium; Nickel Titanium; Stainless Steel; Polymers Stents
• 4) By Mode Of Delivery: Balloon-Expandable Stent; Self-Expanding Stent
• 5) By End-User: Ambulatory Surgical Center; Cardiac Center; Hospital
• Subsegments:
• 1) By Coronary Stents: Drug-Eluting Coronary Stents; Bare Metal Coronary Stents
• 2) By Peripheral Vascular Stents: Drug-Eluting Peripheral Stents; Bare Metal Peripheral Stents
• 3) By EVAR Stent Grafts (Endovascular Aneurysm Repair): Aortoiliac Stent Grafts; Fenestrated Stent Grafts; Branch Stent Grafts
• Companies Mentioned: Medtronic PLC; Abbott Laboratories; Boston Scientific Corporation; Biotronik SE & Co. KG; B. Braun Melsungen AG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Vascular Stent Market Characteristics

3. Vascular Stent Market Trends And Strategies

4. Vascular Stent Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Vascular Stent Growth Analysis And Strategic Analysis Framework

• 5.1. Global Vascular Stent PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Vascular Stent Market Growth Rate Analysis
• 5.4. Global Vascular Stent Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Vascular Stent Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Vascular Stent Total Addressable Market (TAM)

6. Vascular Stent Market Segmentation

• 6.1. Global Vascular Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Coronary Stents
• Peripheral Vascular Stents
• Evar Stent Grafts
• 6.2. Global Vascular Stent Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Bare Metal Stent
• Bio-engineered Stent
• Bioresorbable Vascular Scaffold
• Drug Eluting Stent
• Dual Therapy Stent
• 6.3. Global Vascular Stent Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Metallic Stents
• Cobalt-Chromium
• Platinum Chromium
• Nickel Titanium
• Stainless Steel
• Polymers Stents
• 6.4. Global Vascular Stent Market, Segmentation By Mode of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Balloon-expandable Stent
• Self-expanding Stent
• 6.5. Global Vascular Stent Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Ambulatory Surgical Center
• Cardiac Center
• Hospital
• 6.6. Global Vascular Stent Market, Sub-Segmentation Of Coronary Stents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Drug-Eluting Coronary Stents
• Bare Metal Coronary Stents
• 6.7. Global Vascular Stent Market, Sub-Segmentation Of Peripheral Vascular Stents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Drug-Eluting Peripheral Stents
• Bare Metal Peripheral Stents
• 6.8. Global Vascular Stent Market, Sub-Segmentation Of EVAR Stent Grafts (Endovascular Aneurysm Repair), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Aortoiliac Stent Grafts
• Fenestrated Stent Grafts
• Branch Stent Grafts

7. Vascular Stent Market Regional And Country Analysis

• 7.1. Global Vascular Stent Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Vascular Stent Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Vascular Stent Market

• 8.1. Asia-Pacific Vascular Stent Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Vascular Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Vascular Stent Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Vascular Stent Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Vascular Stent Market

• 9.1. China Vascular Stent Market Overview
• 9.2. China Vascular Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Vascular Stent Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Vascular Stent Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Vascular Stent Market

• 10.1. India Vascular Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Vascular Stent Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Vascular Stent Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Vascular Stent Market

• 11.1. Japan Vascular Stent Market Overview
• 11.2. Japan Vascular Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Vascular Stent Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Vascular Stent Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Vascular Stent Market

• 12.1. Australia Vascular Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Vascular Stent Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Vascular Stent Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Vascular Stent Market

• 13.1. Indonesia Vascular Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Vascular Stent Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Vascular Stent Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Vascular Stent Market

• 14.1. South Korea Vascular Stent Market Overview
• 14.2. South Korea Vascular Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Vascular Stent Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Vascular Stent Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Vascular Stent Market

• 15.1. Western Europe Vascular Stent Market Overview
• 15.2. Western Europe Vascular Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Vascular Stent Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Vascular Stent Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Vascular Stent Market

• 16.1. UK Vascular Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Vascular Stent Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Vascular Stent Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Vascular Stent Market

• 17.1. Germany Vascular Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Vascular Stent Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Vascular Stent Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Vascular Stent Market

• 18.1. France Vascular Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Vascular Stent Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Vascular Stent Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Vascular Stent Market

• 19.1. Italy Vascular Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Vascular Stent Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Vascular Stent Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Vascular Stent Market

• 20.1. Spain Vascular Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Vascular Stent Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Vascular Stent Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Vascular Stent Market

• 21.1. Eastern Europe Vascular Stent Market Overview
• 21.2. Eastern Europe Vascular Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Vascular Stent Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Vascular Stent Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Vascular Stent Market

• 22.1. Russia Vascular Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Vascular Stent Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Vascular Stent Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Vascular Stent Market

• 23.1. North America Vascular Stent Market Overview
• 23.2. North America Vascular Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Vascular Stent Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Vascular Stent Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Vascular Stent Market

• 24.1. USA Vascular Stent Market Overview
• 24.2. USA Vascular Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Vascular Stent Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Vascular Stent Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Vascular Stent Market

• 25.1. Canada Vascular Stent Market Overview
• 25.2. Canada Vascular Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Vascular Stent Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Vascular Stent Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Vascular Stent Market

• 26.1. South America Vascular Stent Market Overview
• 26.2. South America Vascular Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Vascular Stent Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Vascular Stent Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Vascular Stent Market

• 27.1. Brazil Vascular Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Vascular Stent Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Vascular Stent Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Vascular Stent Market

• 28.1. Middle East Vascular Stent Market Overview
• 28.2. Middle East Vascular Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Vascular Stent Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Vascular Stent Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Vascular Stent Market

• 29.1. Africa Vascular Stent Market Overview
• 29.2. Africa Vascular Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Vascular Stent Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Vascular Stent Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Vascular Stent Market Competitive Landscape And Company Profiles

• 30.1. Vascular Stent Market Competitive Landscape
• 30.2. Vascular Stent Market Company Profiles
  • 30.2.1. Medtronic PLC Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Biotronik SE & Co. KG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. B. Braun Melsungen AG Overview, Products and Services, Strategy and Financial Analysis

31. Vascular Stent Market Other Major And Innovative Companies

• 31.1. Terumo Corporation
• 31.2. Meril Life Sciences Pvt. Ltd.
• 31.3. JOTEC GmbH
• 31.4. W. L. Gore & Associates Inc.
• 31.5. MicroPort Scientific Corporation
• 31.6. Translumina GmbH
• 31.7. Lepu Medical Technology Co. Ltd.
• 31.8. Purple Medical Solution Pvt. Ltd.
• 31.9. Sahajanand Medical Technologies Pvt. Ltd.
• 31.10. Stentys SA
• 31.11. Osypka AG
• 31.12. Cook Medical Inc.
• 31.13. Cordis Corporation
• 31.14. Endologix Inc.
• 31.15. Johnson & Johnson Inc.

32. Global Vascular Stent Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Vascular Stent Market

34. Recent Developments In The Vascular Stent Market

35. Vascular Stent Market High Potential Countries, Segments and Strategies

• 35.1 Vascular Stent Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Vascular Stent Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Vascular Stent Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer